Need a specific person's email?
Browse Reaction Biology's employee directory (about 145 employees) and reveal verified emails free.
Reaction Biology's most common email format is First.Last@reactionbiology.com (ex. John.Doe@reactionbiology.com), used for 94% of reactionbiology.com addresses. Reaction Biology uses 3 email patterns.
| Format | Example | Share of reactionbiology.com |
|---|---|---|
| First.Last@reactionbiology.comMost common | John.Doe@reactionbiology.com | |
| First@reactionbiology.com | John@reactionbiology.com | |
| Last@reactionbiology.com | Doe@reactionbiology.com |
Browse Reaction Biology's employee directory (about 145 employees) and reveal verified emails free.
Biotechnology ResearchPennsylvania, United States51-200 Employees
Reaction Biology Corporation is a biotechnology research firm that supports the development of therapeutic candidates by answering complex scientific questions through contract research services. For more than twenty years, it has served pharmaceutical, academic, and biotech organizations worldwide, functioning as an extension of client teams and applying speed, precision, and rigorous science to advance their research programs. The company operates facilities in Malvern, Pennsylvania, and in Europe to enable streamlined operations and secure handling of sensitive materials across projects. Its discovery and development work covers activities from protein production to in vivo studies, backed by a library of more than 2,000 validated drug targets and over 1,000 cell lines, supported by a global, multidisciplinary team. A notable 2026 development is a collaboration with Fred Hutchinson Cancer Center that culminated in a Nature Biotechnology study profiling kinase inhibitors, illustrating the firm's ongoing engagement in advanced research.
Most common format
First.Last@reactionbiology.com
Example: John.Doe@reactionbiology.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.